News | January 26, 2022
Astec LifeSciences Q3FY22 PAT at Rs 24.74 cr.
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
ICICI Direct gives a preview on the earnings narrative for Q3FY22
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
He has over 22 years of experience in pharmaceutical sales & business development
The company has started manufacturing the Sputnik Light vaccine
First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine
The total cost of the project is estimated at Rs 30 crore
Leaders in scientific and industrial imaging, Atik Cameras prepares for growth as Dr Panos Kapetanopoulos is promoted to DIrector of Atik Cameras Norwich, UK
Subscribe To Our Newsletter & Stay Updated
